Technology: Patient-Specific cells: Beta Cells, Dopaminergic neuron, Hepatocytes Clonexpress has developed a patented technology to develop patient-specific differentiated cell types from human primary fibroblasts and peripheral blood mononuclear cells (PBMNC) by epigenetic induction.
Cost effective development of patient-specific pancreatic beta cells, hepatocytes, neuronal cells from PBMNC provided by investigators. Fast turnaround time (usually about 4-6 weeks). Send enquiries. Technology
Cell Lines available for evaluation and licencing:
Human fetal and adult pancreatic beta cell
Human dopaminergic neuron
Human neuronal progenitor cell
Additional cell lines are under different stages of development.
Clonexpress also provides human CNS primary cells and other primary cell types for in vitro research.